Literature DB >> 16932278

Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implications.

Lionel Groussin1, James A Fagin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16932278     DOI： 10.1038/ncpendmet0161

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  4 in total

1.  The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes.

Authors:  C Regalbuto; P Malandrino; F Frasca; G Pellegriti; R Le Moli; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  2012-07-09       Impact factor: 4.256

Review 2.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

3.  A novel HSP90 modulator with selective activity against thyroid cancers in vitro.

Authors:  Abbas Samadi; Peter Loo; Rithwi Mukerji; Gemma O'Donnell; Xiaqin Tong; Barbara N Timmermann; Mark S Cohen
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

4.  Differential diagnosis of thyroid nodules using fine-needle aspiration cytology and oncogene mutation screening: are we ready?

Authors:  Rosa Marina Melillo; Massimo Santoro; Giancarlo Vecchio
Journal:  F1000 Med Rep       Date:  2010-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.